Quantcast

Latest Clinical research Stories

2014-06-03 08:32:40

NAPA, Calif., June 3, 2014 /PRNewswire/ -- bioskin(®), a leading dermatology CRO offering global clinical trial services, announces they have joined the Medrio partner program. Using Medrio's eClinical Software as a Service (SaaS) suite, bioskin(®) is able to provide clients a user-friendly, efficient and cost-effective solution for data collection. "Our data managers are able to build the study themselves, without losing valuable time communicating with external programmers....

2014-06-03 08:31:03

Company Announces New Relationship with GlobalCare RESEARCH TRIANGLE PARK, N.C., June 3, 2014 /PRNewswire/ -- Marken announced today that they will host an industry workshop to discuss the emerging direct to patient clinical trial market, and that they have forged a global co-marketing relationship with GlobalCare Clinical Trials, Ltd, the leading global provider of ambulant health care services for clinical trials. http://photos.prnewswire.com/prnvar/20110930/NY78064LOGO Marken's...

2014-06-02 23:10:09

On May 23, the FDA notified of a critical shortage of Sterrad Cyclesure 24 Biological Indicators due to a machine performance issue on Advanced Sterilization Products production line. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) June 02, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts...

2014-06-02 16:27:50

LONDON, June 2, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Duodenal Cancer Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/drug_discovery/duodenal_cancer_global_clinical_trials_review_h1_2014.html Duodenal Cancer Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, "Duodenal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Duodenal Cancer clinical trial scenario. This...

2014-06-02 16:26:45

LONDON, June 2, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Meningioma Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/meningioma_global_clinical_trials_review_h1.html Meningioma Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, "Meningioma Global Clinical Trials Review, H1, 2014" provides data on the Meningioma clinical trial scenario. This report provides...

2014-06-02 16:26:42

REDWOOD CITY, Calif., June 2, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that David Chung has resigned as Chief Commercial Officer in order to assume the role of Chief Executive Officer of a medical device company. Richard King, the Company's President and Chief Executive Officer, will...

2014-06-02 16:26:36

LONDON, June 2, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Vulvar Cancer Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/research_rd/clinical_trials/vulvar_cancer_global_clinical_trials_review.html Vulvar Cancer Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, "Vulvar Cancer Global Clinical Trials Review, H1, 2014" provides data on the Vulvar Cancer clinical trial scenario. This...

2014-06-02 12:29:04

Results of CISCRP Study Provide New Insights Into How to Engage the Public and Patients PRINCETON, N.J., June 2, 2014 /PRNewswire/ -- inVentiv Clinical Trial Recruitment Solutions (iCTRS), created to accelerate trials, in collaboration with The Center for Information and Study on Clinical Research Participation (CISCRP) has released the results of research showing public perceptions of clinical trials has improved - good news for companies hoping to recruit for a trial. The...

2014-06-02 08:31:48

CRANBURY, N.J., June 2, 2014 /PRNewswire/ -- Ipca Laboratories Ltd., India (Ipca) and Oncobiologics, Inc., USA (Oncobiologics) announced today the creation of a two-part alliance for the development, manufacture and commercialization of biosimilar monoclonal antibody products. Under the first part of the agreement, Ipca will in-license and commercialize biosimilar products for the India and associated markets. These products will be developed by Oncobiologics to US FDA and EU...

2014-06-02 08:29:48

Lpath will also host an investor call and webcast on Wednesday, June 4, 2014 at 4:30 p.m. EDT to provide updates on ASONEP, iSONEP and other product candidates SAN DIEGO, June 2, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, will present a Trial-in-Progress poster at the American Society of Clinical Oncology (ASCO) meeting in Chicago. The poster, "A Multi-Center, Open Label, Single-Arm, Phase 2 Study of the S1P...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related